Medication info
Jaypolmin Tablets 500mg (Metformin Hydrochloride)

Jaypolmin Tablets 500mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Cheil Pharmaceutical Co., Ltd.
Appearance
White, round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201310829 · Approved 2013.12.23 · Insurance code 645404200

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose needed for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. If the dose exceeds 2000mg, administer in 3 divided doses daily with meals, up to a maximum daily dose of 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and identify the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient whose blood glucose was controlled with diet alone, short-term treatment with this medicine may also be sufficiently effective. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine should be discontinued immediately.
Child dose
Children 10 years of age and older or adolescents who are still growing: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after 1 week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
Cheil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes with insufficient blood sugar control
  • overweight diabetes
View approved original text

This medication is used for the treatment of patients with type 2 diabetes whose blood sugar control is not sufficient with diet and exercise alone. It is particularly effective in overweight adult patients and can be used alone or in combination with other oral hypoglycemic agents or insulin. Additionally, it can be used for children over 10 years old and adolescents in growth either alone or in combination with insulin. This medication helps improve blood sugar control and assists in the management of diabetes.

How to take

Adult dose

The dose should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose needed for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. If the dose exceeds 2000mg, administer in 3 divided doses daily with meals, up to a maximum daily dose of 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and identify the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient whose blood glucose was controlled with diet alone, short-term treatment with this medicine may also be sufficiently effective. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine should be discontinued immediately.

Child dose

Children 10 years of age and older or adolescents who are still growing: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after 1 week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is required. Patients with moderate or greater kidney impairment, dehydration, serious infections, acute myocardial infarction, and other conditions that can affect kidney function should not use this medication. Patients with acute and unstable heart failure or those scheduled for examinations using radiographic iodine contrast media should avoid using this medication and must discontinue it for a period before and after the examination. It should not be administered to patients with hypersensitivity to this medication or to biguanide drugs, nor to patients with type 1 diabetes, diabetic ketoacidosis, severe infections, or trauma. This medication should be temporarily discontinued before and after surgery until kidney function has returned to normal. Caution is necessary for patients with malnutrition, starvation, liver impairment, severe pulmonary function impairment, or excessive alcohol consumption. This medication can cause lactic acidosis, a rare but potentially fatal side effect, so if symptoms such as fatigue, muscle pain, shortness of breath, or abdominal pain occur, immediate medical attention should be sought. Gastrointestinal symptoms (diarrhea, nausea, vomiting) can commonly occur during initial treatment but are usually temporary, so dose adjustments or taking the medication with meals may help. Since this medication is excreted via the kidneys, regular assessment of renal function is necessary, and it should be discontinued if kidney function deteriorates sharply. The blood sugar control effect may change when used in combination with other hypoglycemic agents or specific medications, so patients should inform the healthcare provider of any medications they are taking and closely monitor their blood sugar status. Consumption of alcohol may increase the risk of side effects associated with this medication, so excessive intake should be avoided. During pregnancy, the use of this medication should be done cautiously considering its effects on the fetus, and it should not be used if there is a risk of placental insufficiency or preeclampsia. In lactating individuals, since this medication is secreted in breast milk, careful consideration must be given to breastfeeding and the necessity of treatment. Older adults often experience decreased kidney function, so dose adjustments and regular kidney function monitoring are important. In case of overdose, there is a risk of lactic acidosis, and immediate medical assistance should be sought; if necessary, the medication can be removed via hemodialysis. This medication has the advantage of not causing weight gain, but regular monitoring of blood sugar and kidney function is essential during use. Store this medication out of reach of children and avoid transferring it to other containers.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best kept at room temperature between 1 to 30 degrees Celsius. This helps maintain its effectiveness over time.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.